ConcertAI, a well-known company that offers AI-powered and multi-modal data solutions in healthcare and life sciences, has appointed Casey Graves as the new general manager for Clinical Solutions. In this role, Graves will work on promoting the company’s real-world data and AI projects within oncology research and patient care. His main goal is to speed up innovation and provide meaningful results for healthcare professionals and patients by improving cancer research and treatment methods.
Health Technology Insights: Shilka S. Babu Offers Hybrid Concierge Care Program
In his new position, Graves will set the strategy for ConcertAI’s oncology business and lead teams across product development, data science, clinical operations, and sales. He will also work with different groups in the oncology field, using ConcertAI’s unique data and AI tools to help with research progress. Graves will also manage the CancerLinQ program, helping ConcertAI stay at the forefront of cancer data innovation and application.
Health Technology Insights: Idorsia Launches IMPACT-HTN US Initiative for Hypertension Care
Graves has a solid background in healthcare technology and AI, having held executive roles in software, analytics, and consulting. Recently, he worked as a board advisor and consultant for AI-based healthcare startups. Before that, he was the general manager at Merative, where he led the Truven, Health Insights, and MarketScan businesses, which had a total value of over $200 million. During his time there, he helped the company grow and update its products during the transition from IBM Watson Health. He also held several leadership roles at IBM Watson Health, focusing on services for healthcare providers and digital transformation. Earlier in his career, at Deloitte Consulting, he helped develop AI-based healthcare solutions, started the Innovation Lab, and led the Healthcare Analytics Practice.
Eron Kelly, CEO of ConcertAI, is confident that Graves will be a strong leader for this newly integrated division. Kelly mentioned that Graves brings both strategic thinking and hands-on experience that are vital for growing ConcertAI’s Real-World Evidence, Clinical Trials, and CancerLinQ services. He added that Graves’ knowledge of analytics and his success in scaling health technology platforms align well with ConcertAI’s goals to improve its solutions and better support cancer care teams and patients.
Graves’ appointment is a big step in ConcertAI’s mission to drive clinical progress through data and AI. His mix of business leadership, deep understanding of clinical needs, and strong technology skills is expected to shape the future of the company’s clinical solutions. With this new leadership, ConcertAI intends to increase its influence on oncology research and patient care worldwide.
Health Technology Insights: Health In Tech Expands Leadership to Boost AI and Revenue
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
